Skip to Main Content
Table 1

Cardiovascular autonomic tests and suggested indications for their use

Clinical diagnosisResearchEnd point in clinical trials
HR cardiovascular tests Yes Yes Yes 
Orthostatic hypotension test Yes Yes No (low sensitivity) 
QT interval Yes (additional information and risk stratification) Yes No (low sensitivity) 
ABPM for dipping status Yes (risk stratification) Yes No (low sensitivity) 
HRV time- and frequency-domain indices Yes (early additional information and risk stratification) Yes Yes 
BRS measures No (offers early additional information and risk stratification but low availability) Yes Yes 
Scintigraphic studies No (low availability and limited standardization) Yes Yes 
MNSA No (low availability and limited data in CAN) Yes Possible (used in lifestyle intervention trials in obesity) 
Catecholamine assessment No (low availability) Yes Possible (used in lifestyle intervention trials in obesity) 
Clinical diagnosisResearchEnd point in clinical trials
HR cardiovascular tests Yes Yes Yes 
Orthostatic hypotension test Yes Yes No (low sensitivity) 
QT interval Yes (additional information and risk stratification) Yes No (low sensitivity) 
ABPM for dipping status Yes (risk stratification) Yes No (low sensitivity) 
HRV time- and frequency-domain indices Yes (early additional information and risk stratification) Yes Yes 
BRS measures No (offers early additional information and risk stratification but low availability) Yes Yes 
Scintigraphic studies No (low availability and limited standardization) Yes Yes 
MNSA No (low availability and limited data in CAN) Yes Possible (used in lifestyle intervention trials in obesity) 
Catecholamine assessment No (low availability) Yes Possible (used in lifestyle intervention trials in obesity) 

ABPM, ambulatory BP monitoring; HRV, heart rate variability; MNSA, muscle sympathetic nerve activity.

Close Modal

or Create an Account

Close Modal
Close Modal